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Abstract 
The von Hippel-Lindau (VHL) tumour suppressor gene is biallelically inactivated in the 
majority of cases of clear cell renal cell carcinoma (ccRCC), however Vhl knockout mouse 
models do not recapitulate human ccRCC, implying that additional mutations are required for 
tumour formation. Mutational inactivation of VHL sensitises renal epithelial cells to lose the 
primary cilium in response to other mutations or extracellular stimuli. Cilia loss is believed to 
represent a second hit in VHL mutant cells that causes the development of cystic lesions that 
in some cases can progress to ccRCC. Supporting this idea, genetic ablation of the primary 
cilium by deletion of the kinesin family member 3A (Kif3a) gene cooperates with loss of Vhl to 
accelerate cyst formation in mouse kidneys. Additionally, aged Vhl/Trp53 double mutant mice 
develop renal cysts and tumours at a relatively low incidence, suggesting that there is a 
genetic cooperation between VHL and TP53 mutation in the development of ccRCC. Here we 
generated renal epithelium-specific Kif3a/Trp53 and Vhl/Kif3a/Trp53 mutant mice to 
investigate whether primary cilium deletion would accelerate the development of cystic 
precursor lesions or cause their progression to ccRCC. Longitudinal microcomputed 
tomography imaging and histopathological analyses revealed an increased rate of cyst 
formation, increased proportion of cysts with proliferating cells, higher frequency of atypical 
cysts as well as the development of neoplasms in Vhl/Kif3a/Trp53 mutant kidneys compared 
to Kif3a/Trp53 or Vhl/Kif3a mutant kidneys. These findings demonstrate that primary cilium 
loss in addition to Vhl and Trp53 losses promotes the transition towards malignancy and 
provide further evidence that the primary cilium functions as a tumour suppressor organelle 
in the kidney. 
 
Key words 
Clear cell renal cell carcinoma, von Hippel-Lindau, primary cilium, Trp53, mouse model 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
Introduction 
Clear cell renal cell carcinoma (ccRCC) is the most common type of renal cancer, accounting 
for approximately 70% of all cases [1]. The von Hippel-Lindau (VHL) tumour suppressor gene 
is biallelically inactivated in over 90% of sporadic cases of ccRCC [2]. Inheritance of a mutant 
allele of the VHL gene results in the autosomal dominant VHL syndrome, which is 
characterised not only by the development of ccRCC but also by renal and pancreatic cysts as 
well as tumours in the central nervous system, retina, pancreas and ear [3-5]. Kidneys of 
patients with VHL disease exhibit a range of lesions that likely represent precursors of ccRCC 
[3], including simple cysts that are lined by a single layer of epithelial cells and atypical cysts 
that display multi-layered epithelial structures that resemble small foci of ccRCC growing in 
the wall of the cyst. It has been shown that the growth of these tumour cells in a subset of 
atypical cysts may fill the cystic lesion to generate a solid ccRCC or a solid ccRCC with a cystic 
component [6]. About 5% of all VHL mutant ccRCCs occurring sporadically lack a solid tumour 
component and are classified as multilocular multicystic renal cell carcinomas in which clear 
cell tumour cells grow within and between the walls of multiple cysts. The growth pattern of 
this neoplasm of low malignant potential is reminiscent of the appearance of atypical cysts in 
VHL patients, suggestive of a cystic origin of this tumour entity.  However, while the transition 
from a cystic lesion to a solid ccRCC has been observed to occur at low frequency in 
longitudinal imaging studies of VHL patients, the majority of large cystic lesions do not 
develop into solid ccRCCs within a short timeframe [6] implying that not all cysts have the 
propensity to develop into ccRCCs. Additionally, small solid micro-ccRCC lesions can be 
observed in histological sections of VHL patient kidneys and longitudinal imaging studies of 
VHL patients demonstrate the growth of solid ccRCCs from small solid lesions [6]. Thus, the 
initiation of ccRCC can occur from a cystic precursor lesion or a solid precursor lesion [7, 8].  
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The loss of function of the pVHL protein alone is insufficient to induce ccRCC formation 
despite being necessary for the growth of established VHL-mutant ccRCC cell lines in mouse 
xenograft assays [9]. On one hand, ccRCC arises relatively infrequently in kidneys of patients 
with VHL disease considering the vast number of VHL null cells that these kidneys contain 
[10] and on the other hand, none of the many Vhl knockout mouse models that have been 
generated developed renal tumours [3]. These arguments support the hypothesis that 
additional genetic mutations act in cooperation with the loss of VHL in causing tumour 
formation. 
 
One of pVHL’s many biological functions is stabilisation of the microtubule core of the 
primary cilium, a microtubule-based organelle that acts as a sensor of chemical and 
mechanical signals [11]. Loss of functionality or structure of the primary cilium causes 
polycystic diseases in the kidney [12]. Cystic lesions in VHL patients exhibit a reduced 
frequency of ciliated epithelial cells [13] and cells of human ccRCCs have a very low frequency 
of primary cilia in comparison to normal renal epithelia and in comparison to other types of 
renal cell carcinoma [14]. However, Vhl knockout in renal epithelial cells is not sufficient to 
cause loss of the primary cilium in vivo [13]. Rather, loss of pVHL function sensitises cells to 
lose the primary cilium in response to cellular signals that lead to inactivation of GSK3β [13]. 
The PTEN tumour suppressor gene is genetically inactivated in approximately 5% of human 
ccRCCs [2, 15]. Constitutive activation of the PI3K signalling pathway via deletion of Pten 
leads to inactivation of GSK3β and when combined with deletion of Vhl causes a reduction in 
the frequency of ciliated epithelial cells and leads to cyst formation in mouse kidneys [16]. 
These findings argue that secondary genetic mutations or signalling alterations can cause VHL 
mutant cells to lose the primary cilium, initiating cystic lesions that can potentially lead to 
ccRCC [16]. 
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This idea has recently been further supported by studies investigating genetic ablation of the 
primary cilium in the kidney. Kinesin family member 3A (Kif3a) is a component of the kinesin-
II microtubule motor complex and its deletion prevents the formation of the primary cilium in 
cells and leads to cyst formation in mouse kidneys [17]. Co-deletion of Vhl and Kif3a 
accelerates cyst initiation and increases the total number of cysts per kidney as well as the 
frequency of atypical cysts [18]. However, because these atypical cysts did not form tumours 
it is likely that additional genetic alterations are required for progression to ccRCC.  
 
Analyses of single biopsies of human ccRCC revealed that the TP53 tumour suppressor gene is 
mutated in 2-8% of ccRCCs [2, 15, 19] and that genetic alterations in regulators of p53, 
including MDM2, ATM, CHEK2 and CDKN2A occur mutually exclusively to TP53 mutations, 
arguing that the p53 pathway is functionally altered in approximately 20-25% of ccRCCs [2]. 
Analyses of 10 ccRCCs by sequencing multiple biopsies from different regions of each tumour 
revealed that 40% of these tumours harboured TP53 mutations in at least one tumour region, 
implying that the large scale tumour sequencing studies have likely underestimated the 
frequency of TP53 mutations that can be present in spatially distinct sub-clonal populations 
within ccRCC tumours [20].  Supporting the functional relevance of p53 pathway alteration in 
ccRCC, co-deletion of Vhl with Trp53 in the mouse renal epithelium not only led to the 
formation of simple and atypical cystic lesions but also to tumours that share several 
histological and molecular similarities with ccRCC [19]. Since Vhl/Trp53 double mutant mice 
developed cysts and tumours with late onset and with relatively few lesions per kidney and 
since Vhl/Kif3a double mutant mice developed many cysts within a few months of gene 
deletion we generated a mouse model that combines the mutation of Vhl, Trp53 and Kif3a to 
ask whether loss of these tumour suppressors together with ablation of the primary cilium 
might lead to the formation of ccRCC. 
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Materials and Methods 
Animals 
Mice expressing a tamoxifen-inducible kidney-specific Cre recombinase under the Ksp1.3 
promoter [21] were crossed with Kif3afl/fl, Vhlfl/fl and/or Trp53fl/fl animals [18,19]. To achieve 
gene deletion 6-week old mice were fed with tamoxifen-containing food (Harlan 
Laboratories) for 2 weeks. Non-Cre transgenic littermates were used as controls. Mouse 
experiments were conducted under experimental license 131/2012 from the Veterinary 
Office of the Canton of Zurich.  
 
Genomic DNA isolation and sequencing 
Formalin-fixed, paraffin embedded kidney sections were dipped in Xylol for 5 minutes and 
then air-dried. Tissue was scratched off the slides and genomic DNA was isolated with the 
Arcturus PicoPure DNA Extraction Kit (Life Technologies). Sequences of the primers used for 
detecting the recombined alleles and the S6 internal control are given in the Supplementary 
Information. 
 
Microcomputed tomography (μCT) imaging 
Intravenous injections of Visipaque 270 (GE Healthcare) were performed at 8μl/g of body 
weight [22]. Images were obtained with a Quantum FX microCT (Perkin Elmer) with the 
following settings: 100 μA, 90 kV, respiratory gating and fine scanning. 
 
Immunohistochemistry and immunofluorescence 
Immunohistochemistry and immunofluorescence were conducted using previously described 
methods [18] with the following antibodies to: acetylated tubulin (T6793; Sigma-Aldrich), 
cleaved Caspase 3 (9661; Cell Signaling), HIF-1α (NB100-105; Novus Biologicals), Ki67 
(M7248; Dako), P-4E-BP1 (Thr37/46) (2855; Cell Signaling), P-ERK1/2 (Thr202/Tyr204) 
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(9101; Cell Signaling), Pbrm1 (A-301-591A; Bethyl Laboratories) and Tri-Methyl-Histone H3 
(Lys36) (4909; Cell Signaling). The secondary antibodies used were: goat anti-mouse Alexa 
488 (A-11001; Life Technologies and horseradish peroxidase-coupled anti-mouse (31430; 
ThermoFisher Scientific). 
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Results 
To investigate the consequences of combined Vhl, Trp53 and Kif3a deletion in the mouse renal 
epithelium we generated Ksp1.3-CreERT2 Tg/+; Kif3afl/fl; Vhlfl/fl; Trp53fl/fl and Ksp1.3-
CreERT2 Tg/+; Kif3afl/fl; Trp53fl/fl mice. Non-transgenic (Ksp1.3-CreERT2 +/+) littermates 
were used as controls.  All mice were fed tamoxifen-containing food at 6 weeks of age for 2 
weeks to induce Cre activation. We chose this protocol as we have previously empirically 
determined that it allows a moderate level of gene deletion that leads to a moderate number 
of lesions, allowing the mice to be aged for as long as possible before the presence of many 
and large cysts might impair renal function. Hereafter control mice are referred to as 
Kif3afl/fl;Vhlfl/fl;Trp53fl/fl or Kif3afl/fl;Trp53fl/fl and transgenic mice as 
Kif3aΔ/Δ;VhlΔ/Δ;Trp53Δ/Δ or Kif3aΔ/Δ;Trp53Δ/Δ. Deletion of both or all three genes in the 
respective kidneys was confirmed by recombination-specific PCR of genomic DNA (Figure 1A). 
Vhl null cells are commonly identified by nuclear accumulation of hypoxia-inducible factor 1-
α (HIF-1α) [16] whilst functional Kif3a deletion can be determined by the absence of primary 
cilia detected by loss of staining for acetylated tubulin, which normally stains primary cilia 
very strongly [17]. p53 is not detectable in normal renal cells and its loss can therefore not be 
assessed by immunohistochemistry [19]. All cystic epithelial cells lacked primary cilia in both 
genotypes (Figure 1B) whilst HIF-1α nuclear staining was present solely in 
Kif3aΔ/Δ;VhlΔ/Δ;Trp53Δ/Δ and not in Kif3aΔ/Δ;Trp53Δ/Δ epithelial cells of cysts (Figure 1B), 
functionally confirming the deletions of Kif3a and Vhl. Additionally, in 
Kif3aΔ/Δ;VhlΔ/Δ;Trp53Δ/Δ kidneys we frequently observed histologically normal renal 
tubules that contained single or multiple cells that displayed strong nuclear accumulation of 
HIF-1α (data not shown) indicative of Cre activation during the period of tamoxifen feeding. 
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This observation argues that not all mutant cells form lesions and that the frequency of gene 
deletion is not a limitation to the formation of lesions. 
 
We monitored renal cyst development in each animal over time via microcomputed 
tomography (μCT). Animals under anaesthesia received an intravenous injection of a contrast 
agent that permits visualisation of the kidneys in μCT imaging due to the concentration of the 
contrast agent in the renal tubular fluid [18, 22]. Cysts or other lesions fail to concentrate the 
contrast agent and are displayed as dark areas in the images [18, 23]. Mice were imaged every 
4 weeks post-tamoxifen treatment for 40 weeks and kidneys were isolated after the last 
imaging (Figure 2). In a few cases in which the cystic burden was very high the mice were 
sacrificed at earlier timepoints. Cysts were observed in all transgenic animals (Figures 2B and 
2C) whilst control animals did not develop any cysts (Figure 2A). The cystic burden observed 
in histological sections of whole kidneys correlated with the μCT imaging (Figures 2A, 2B and 
2C). Both genotypes exhibited mainly a moderate cystic phenotype but some mice developed 
a severe cystic phenotype. This inter-animal variation is most likely due to variations in the 
efficiency of tamoxifen-induced Cre activation. Compared to Kif3aΔ/Δ;Trp53Δ/Δ mice the 
Kif3aΔ/Δ;VhlΔ/Δ;Trp53Δ/Δ mice developed cysts at an earlier age (Figure 2D). The onset of 
cyst formation in Kif3aΔ/Δ;VhlΔ/Δ;Trp53Δ/Δ mice was almost identical to the onset seen in 
our previous studies with Kif3aΔ/Δ;VhlΔ/Δ mice while the onset in Kif3aΔ/Δ;Trp53Δ/Δ mice 
was faster and more penetrant than seen previously in Kif3aΔ/Δ mice [18]. However, analysis 
of histological sections showed that both genotypes harboured equivalent numbers of cysts 
per kidney section at the end time point (Figure 2E).  
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Histological analyses revealed that both genotypes predominantly developed simple cysts 
(Figures 3A and 3E), which are lined by a single layer of epithelial cells.  Some cystic lesions in 
kidneys of VHL patients display an atypical morphology characterised by a multi-layered 
epithelium or epithelial projections into the cystic lumen. These atypical cysts are considered 
to be pre-malignant lesions. Similar lesions were observed in Kif3aΔ/Δ;VhlΔ/Δ;Trp53Δ/Δ mice 
(Figures 3F) and more rarely in Kif3aΔ/Δ;Trp53Δ/Δ mice (Figures 3B and 3C). Moreover, in 
comparison to Kif3aΔ/Δ;Trp53Δ/Δ mice and the previously published Kif3aΔ/Δ;VhlΔ/Δ mice 
[18], Kif3aΔ/Δ;VhlΔ/Δ;Trp53Δ/Δ animals developed lesions that appeared to represent a 
further step in the process of malignant progression including cysts with larger neoplastic 
projections (Figures 3G and 3H) and occasional small solid neoplasms (Figures 3I and 3J). 
These neoplastic lesions were between 50 and 250 μm in diameter.  In comparison to normal 
renal epithelial cells (Figure 3K) the cells in atypical cysts and neoplasms displayed weak 
cytoplasmic eosin staining and a clear cell appearance that is similar to the appearance of 
clear cell tumour cells in ccRCC (Figure 3L-N). While it appears likely that simple cysts, 
atypical cysts and neoplasms represent a continuous spectrum of lesions, for the purposes of 
quantification we defined atypical cysts to be cysts in which the maximum thickness of multi-
layered cellular growth was three cells deep and collectively termed lesions in which cellular 
growths contained four or more cell layers (either cystic lesions or solid lesions) as 
neoplasms. These analyses demonstrated an increased proportion of both atypical cysts and 
of neoplasms in Kif3aΔ/Δ;VhlΔ/Δ;Trp53Δ/Δ animals (approximately 15% combined) 
compared to Kif3aΔ/Δ;Trp53Δ/Δ animals (approximately 5% combined)  (Figure 3O). In 
comparison, the percentage of atypical cysts seen in our previous studies of Kif3aΔ/Δ and 
Kif3aΔ/Δ;VhlΔ/Δ mice were 2% and 8% respectively [18]. Thus, the triple mutant combination 
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greatly increases the number of cysts that display atypical and neoplastic epithelial linings. 
We conclude that triple deletion of Kif3a, Vhl and Trp53 in kidney epithelial cells in vivo 
reproduces the proposed model of cystic ccRCC progression where simple cysts evolve to 
atypical cysts and then on to neoplasms.  
 
Cysts in VHL patient kidneys and human ccRCC frequently display activation of mTORC1 
signalling [2, 15, 16]. Primary cilia have also been implicated in the regulation of PI3K-
mTORC1 signalling [24, 25]. Immunohistochemical staining using an antibody against 
phosphorylated Thr37/Thr46-4E-BP1, a readout of mTORC1 activation, revealed that cysts in 
Kif3aΔ/Δ;VhlΔ/Δ;Trp53Δ/Δ kidneys displayed more frequent phosphorylation of 4E-BP1 than 
cysts in Kif3aΔ/Δ;Trp53Δ/Δ kidneys (Figures 4A and 4C). A similar result was obtained with 
analysis of phosphorylated Thr202/Tyr204-ERK1/2, which is activated downstream of 
numerous growth factor signalling pathways (Figures 4B and 4D). We next asked whether the 
increased activation of these pro-proliferative signalling pathways was associated with 
increased proliferation of cystic cells by staining histological sections of mice with 
comparable moderate phenotypes with an antibody against Ki67, a marker of proliferative 
cells. This staining revealed a mixture of cysts with and without proliferating cells (Figure 4G). 
Quantification of Ki67 positive (Ki67+) cysts revealed twice as many proliferating cysts in 
Kif3aΔ/Δ;VhlΔ/Δ;Trp53Δ/Δ kidneys as in Kif3aΔ/Δ;Trp53Δ/Δ kidneys (Figure 4E). However, no 
differences were observed between the two genotypes in relation to the frequency of Ki67+ 
cells within proliferating cysts (Figure 4F). There were no differences between genotypes in 
the extent of apoptosis as measured by nuclear immunoreactivity using an antibody against 
cleaved (activated) caspase 3 (Figures 4H and 4I). These data show that triple mutant cysts 
are more likely to be proliferating and growing than the double mutant cysts and this may 
contribute to the enhanced transition to a more malignant phenotype. 
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Since atypical cysts and neoplasms arise less frequently than simple cysts it is possible that 
additional genetic alterations may have occurred in these cells to cause this transition to a 
more neoplastic phenotype. Inactivating mutations in PBRM1, BAP1 and SETD2 arise 
frequently in human ccRCC [2, 15]. While the microscopic nature of the neoplastic lesions in 
Kif3aΔ/Δ;VhlΔ/Δ;Trp53Δ/Δ kidneys prevented genetic analyses, we utilised 
immunohistochemistry to assess potential genetic deletion or truncation of Pbrm1 using an 
antibody against PBRM1. We assessed potential inactivating mutations of Setd2 using an 
antibody against histone H3 trimethylated lysine 36 (H3K36me3), a protein modification that 
is entirely dependent on SETD2 function. A functioning antibody against mouse BAP1 is not 
commercially available. These studies revealed PBRM1 and H3K36me3 immunoreactivity in 
all simple cysts, atypical cysts and neoplasms (Supplementary Figures 1A and 1B) arguing 
against the deletion or mutation of these genes as being a contributing factor in the evolution 
of these lesions. 
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Discussion 
We recently showed that combined deletion of Vhl and Kif3a accelerates renal cyst formation 
and increases the total number of cysts and the proportion of atypical cysts when compared 
with Kif3a deletion alone [18].  We argued that loss of the primary cilium cooperates with loss 
of pVHL function to promote cyst formation and that additional mutations are likely to be 
required to progress toward ccRCC via a cyst-dependent pathway. Previously we also showed 
that combined deletion of Vhl and Trp53 in mice leads to the formation of simple and atypical 
cysts as well as tumours in the kidneys [19]. However, limitations of the Vhl/Trp53 model 
were the low incidence and long latency of tumour formation (1 year) and the absence of 
clearly malignant ccRCC lesions. To attempt to accelerate the formation of precursor lesions 
and potentially generate a mouse model that progresses to ccRCC we combined these three 
genotypes to reproduce the mutational and cellular changes that are found in some cases of 
human ccRCC. We found that the triple loss of Vhl, Kif3a and Trp53 in mouse renal epithelia 
results in a variety of simple and atypical cystic lesions and neoplasms but is also insufficient 
to cause ccRCC. In the cyst-dependent pathway of ccRCC progression simple cysts are 
believed to become atypical cysts that first develop micro-foci that resemble ccRCC and these 
then progress to form malignant ccRCC tumours. The increased rate of cyst formation, the 
increased proportion of cysts with proliferating cells, the higher frequency of atypical cysts as 
well as the development of neoplasms in Kif3aΔ/Δ;VhlΔ/Δ;Trp53Δ/Δ compared to 
Kif3aΔ/Δ;Trp53Δ/ Δ mice indicates that primary cilium loss in addition to Vhl and Trp53 loss 
promotes the transition towards malignancy.  
 
Notably, kidneys of Kif3aΔ/Δ;VhlΔ/Δ;Trp53Δ/Δ mice 10 months after gene deletion not only 
displayed cystic lesions but also displayed many histologically normal tubules in which some 
renal epithelial cells exhibited nuclear accumulation of HIF-1α, indicative of gene deletion in 
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these cells during the period of tamoxifen feeding. Thus, the combination of triple loss of Vhl, 
Kif3a and Trp53 does not automatically cause cyst formation even after a long time period. 
This could be explained by the slow cell-turnover of the kidney tissue [26] and by findings 
showing that cyst formation following loss of the primary cilium requires cellular turnover 
[23, 27]. 
 
Our data demonstrate that loss of the primary cilium is not a strong driver of oncogenic 
transformation, even in a genetic background that is prone to form renal tumours. By 
inference, we argue that loss of the primary cilium acts as an important driver of the initiation 
of proliferation of VHL mutant cells to form precursor lesions in human kidneys, providing an 
expanded pool of proliferating cells that can subsequently accumulate mutations that 
cooperate with VHL mutation to fully transform renal epithelial cells and drive the formation 
of ccRCC. In this context, recent large-scale sequencing studies have identified frequent 
mutations in several tumour suppressor genes located on human chromosome 3p such as 
PBRM1, SETD2 and BAP1 [2, 15]. Interestingly, deletion of Vhl combined with heterozygous 
loss of Bap1 has been shown to produce not only cystic lesions but also small renal tumours 
that reproduce some, but not all, of the histological and molecular features of human ccRCC 
[28]. After several decades of trying, ccRCC remains one of the few human tumours for which 
there is still no adequate autochthonous mouse model that fully reproduces the histological 
and clinical features of the disease, demonstrating that the molecular causes of the formation 
of this tumour type have not yet been fully elucidated. 
 
In summary, we have developed a mouse model that recapitulates a variety of pre-malignant 
lesions that occur in the formation of ccRCC tumours in humans as well as further validated 
the use of contrast-assisted μCT imaging for the longitudinal monitoring of renal cystic 
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phenotypes. This mouse model will be useful for testing therapeutic strategies that could be 
employed to prevent the emergence of precursor lesions and ccRCC tumours in VHL patients. 
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for the floxed (fl) and recombined (Δ) alleles were used. The promoter region of ribosomal 
protein S6 (S6) acted as internal DNA quality and PCR control. (B) Representative images of 
H&E, anti-HIF-1α and anti-acetylated tubulin immunostainings of normal and cystic (Cy) 
kidney regions of Kif3aΔ/Δ;VhlΔ/Δ;Trp53Δ/Δ and Kif3aΔ/Δ;Trp53Δ/Δ mice. H&E, haematoxylin 
and eosin. Scale bars, 20 μM.  
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representative histological section of each of the imaged mice at 40 weeks (right). The cystic 
phenotypes were visually classified as moderate or severe. H&E, haematoxylin and eosin. 
Scale bars, 1 mm in H&E images. (D) Percentages of animals with visually recognisable cysts 
in μCT images at different timepoints after tamoxifen treatment. Kif3aΔ/Δ;VhlΔ/Δ;Trp53Δ/Δ 
(n=15) and Kif3aΔ/Δ;Trp53Δ/ Δ (n=17). (E) Number of cysts per kidney section established 
after visual analysis of histological sections. Mean ± SEM of Kif3aΔ/Δ;VhlΔ/Δ;Trp53Δ/Δ (n=15) 
and Kif3aΔ/Δ;Trp53Δ/ Δ (n=23). n.s, not significant (P>0.05, Student’s unpaired t test). 
 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
Figure 3. 
than Kif3
atypical c
Represent
Kif3aΔ/Δ;
aΔ/Δ;Trp5
ysts (B, C)
ative H&E 
VhlΔ/Δ;Tr
3Δ/ Δ anim
 and a ve
stainings o
p53Δ/Δ m
als. (A-D
ry small n
f a simple 
ice develo
) Represen
eoplasm 
cyst (E), a
p neopla
tative H&E
(D) from 
typical cys
sms and m
 stainings
Kif3aΔ/Δ;T
t (F), neop
ore atyp
 of a simpl
rp53Δ/ Δ m
lastic cysts
ical cysts
e cyst (A),
ice. (E-J)
 (G and H)
 
 
 
 
 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
and solid neoplasms (I and J) from Kif3aΔ/Δ;VhlΔ/Δ;Trp53Δ/Δ mice. (K-N) Representative 
H&E stainings of normal renal tubules (K) and clear cells in an atypical cyst (L), neoplastic 
cyst (M) and solid neoplasm (N). (O) Proportions of the different types of lesions scored by 
analysis of histological sections. Kif3aΔ/Δ;VhlΔ/Δ;Trp53Δ/Δ (n=15 mice) and 
Kif3aΔ/Δ;Trp53Δ/ Δ (n=23 mice). Scale bars, 50 μM. 
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right) from Kif3aΔ/Δ;VhlΔ/Δ;Trp53Δ/Δ mice. (B) Representative negative and positive staining 
of P-ERK1/2 (Thr202/Tyr204) in a simple cyst and positive staining in an atypical cyst and 
neoplasm (left to right) from Kif3aΔ/Δ;VhlΔ/Δ;Trp53Δ/Δ mice. (C-E) Frequency of P-4E-BP1 
positive cysts (C), P-ERK1/2 positive cysts (D) and cysts containing Ki67+ cells (E) per kidney 
section. Mean ± SEM of Kif3aΔ/Δ;VhlΔ/Δ;Trp53Δ/Δ (n=10 mice) and Kif3aΔ/Δ;Trp53Δ/Δ (n=10 
mice). ** P<0.01; *** P<0.001 (Student’s unpaired t test). (F) Percentage of Ki67+ cells per 
Ki67+ cyst. Mean ± SEM of Kif3aΔ/Δ;VhlΔ/Δ;Trp53Δ/Δ (n=25 cysts) and Kif3aΔ/Δ;Trp53Δ/ Δ 
(n=26 cysts). n.s, not significant (P>0.05, Student’s unpaired t test). (G) Representative 
positive (left and middle) and negative (right) Ki67 immunostainings of kidney cysts. (H) 
Representative negative (left) and positive (right) cleaved Caspase 3 immunostainings of 
kidney cysts. Scale bars, 50 μM. (I) Percentages of cysts containing cleaved Caspase 3 positive 
cells. Mean ± SEM of Kif3aΔ/Δ;VhlΔ/Δ;Trp53Δ/Δ (n=10) and Kif3aΔ/Δ;Trp53Δ/ Δ (n=10). n.s, 
not significant (P>0.05, Student’s unpaired t test). Scale bars, 50 μM. 
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